Open main menu

Pages with the most revisions

Showing below up to 250 results in range #51 to #300.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Absorbed fraction‏‎ (5 revisions)
  2. Effective half-life‏‎ (4 revisions)
  3. Averted dose‏‎ (4 revisions)
  4. Kp index‏‎ (4 revisions)
  5. Protective action‏‎ (4 revisions)
  6. Reference Animal and Plant‏‎ (4 revisions)
  7. Source-related assessment‏‎ (4 revisions)
  8. Forbiddenness‏‎ (4 revisions)
  9. Aerodynamic diameter‏‎ (4 revisions)
  10. ICRP‏‎ (4 revisions)
  11. Diagnostic reference level‏‎ (4 revisions)
  12. Risk‏‎ (4 revisions)
  13. Senescence‏‎ (4 revisions)
  14. Reference bioassay function‏‎ (4 revisions)
  15. Air-kerma, product‏‎ (4 revisions)
  16. Fractionation sensitivity‏‎ (4 revisions)
  17. Optimisation‏‎ (4 revisions)
  18. Sievert‏‎ (4 revisions)
  19. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  20. S coefficient (radiation weighted)‏‎ (4 revisions)
  21. Non-maleficence‏‎ (4 revisions)
  22. High linear energy transfer radiation‏‎ (4 revisions)
  23. Direct bioassay‏‎ (4 revisions - redirect page)
  24. Bioassay‏‎ (4 revisions)
  25. Calculating Radon Doses‏‎ (4 revisions)
  26. Computed tomography dose index‏‎ (4 revisions)
  27. Mass median diameter‏‎ (4 revisions)
  28. Alpha decay‏‎ (4 revisions)
  29. Effective charge number‏‎ (4 revisions)
  30. Math‏‎ (4 revisions)
  31. Programmed cell death‏‎ (4 revisions)
  32. Dose equivalent‏‎ (3 revisions)
  33. Field-size effect (Volume effect)‏‎ (3 revisions)
  34. Gastrointestinal syndrome‏‎ (3 revisions)
  35. Wisdom‏‎ (3 revisions)
  36. Biomedical research volunteer‏‎ (3 revisions)
  37. Cardiomyopathy‏‎ (3 revisions)
  38. Dose limit‏‎ (3 revisions)
  39. Target region‏‎ (3 revisions)
  40. Flexible tissues‏‎ (3 revisions)
  41. Guide to the System of Radiological Protection‏‎ (3 revisions)
  42. Autonomy‏‎ (3 revisions)
  43. Dose‏‎ (3 revisions)
  44. Dose limits‏‎ (3 revisions)
  45. Fluence‏‎ (3 revisions)
  46. Constancy test‏‎ (3 revisions)
  47. DS02‏‎ (3 revisions)
  48. Fluoroscopically guided interventions‏‎ (3 revisions)
  49. Annual dose‏‎ (3 revisions)
  50. Potential exposure‏‎ (3 revisions)
  51. Rigidity threshold‏‎ (3 revisions)
  52. Dose of record (E)‏‎ (3 revisions)
  53. Low Earth orbit‏‎ (3 revisions)
  54. Accountability‏‎ (3 revisions)
  55. X ray‏‎ (3 revisions)
  56. Half-life, physical‏‎ (3 revisions)
  57. Cell death‏‎ (3 revisions)
  58. Contamination‏‎ (3 revisions)
  59. Exponential survival curve‏‎ (3 revisions)
  60. Unsealed source‏‎ (3 revisions)
  61. Xerostomia‏‎ (3 revisions)
  62. Annual limit on intake‏‎ (3 revisions)
  63. Dose per content function‏‎ (3 revisions)
  64. Interphase death‏‎ (3 revisions)
  65. Equity‏‎ (3 revisions)
  66. Test‏‎ (3 revisions)
  67. Graded approach‏‎ (3 revisions)
  68. Public exposure‏‎ (3 revisions)
  69. Fractionation‏‎ (3 revisions)
  70. Uptake‏‎ (3 revisions)
  71. Active (red) bone marrow‏‎ (3 revisions)
  72. Utilitarian ethics‏‎ (3 revisions)
  73. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  74. Operational quantity‏‎ (3 revisions)
  75. Value judgement‏‎ (3 revisions)
  76. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  77. Coster-Kronig transition‏‎ (3 revisions)
  78. Emergency preparedness‏‎ (3 revisions)
  79. Valvular heart disease‏‎ (3 revisions)
  80. Gray‏‎ (3 revisions)
  81. Personal dose equivalent‏‎ (3 revisions)
  82. Principle of justification‏‎ (3 revisions)
  83. Radiofrequency ablation‏‎ (3 revisions)
  84. Iso-effect plots‏‎ (3 revisions)
  85. Emergency procedures‏‎ (3 revisions)
  86. Lifetime risk estimates‏‎ (3 revisions)
  87. Absolute risk‏‎ (3 revisions)
  88. Virtue ethics‏‎ (3 revisions)
  89. Auger transition‏‎ (3 revisions)
  90. Bystander effect‏‎ (3 revisions)
  91. Derived air concentration‏‎ (3 revisions)
  92. Dignity‏‎ (3 revisions)
  93. Isomers‏‎ (3 revisions)
  94. Employer‏‎ (3 revisions)
  95. Activity median thermodynamic diameter‏‎ (3 revisions)
  96. Voxel phantom‏‎ (3 revisions)
  97. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  98. Complex tissues‏‎ (3 revisions)
  99. Growth fraction‏‎ (3 revisions)
  100. Organ dose equivalent‏‎ (3 revisions)
  101. Excretion rate (instantaneous)‏‎ (3 revisions)
  102. Extrathoracic airways‏‎ (3 revisions)
  103. Galactic cosmic radiation‏‎ (3 revisions)
  104. Growth hormone (somatotropin)‏‎ (3 revisions)
  105. ICRP Publication 103‏‎ (3 revisions)
  106. Spread-out Bragg peak‏‎ (3 revisions)
  107. Fairness‏‎ (3 revisions)
  108. Absorption‏‎ (3 revisions)
  109. Gamma ray‏‎ (3 revisions)
  110. Recovery‏‎ (3 revisions)
  111. DNA damage signalling‏‎ (3 revisions)
  112. Retrievability‏‎ (2 revisions)
  113. Immune system‏‎ (2 revisions)
  114. Institutional control‏‎ (2 revisions)
  115. Stakeholder‏‎ (2 revisions)
  116. Environmental radiation protection‏‎ (2 revisions)
  117. Tachycardia‏‎ (2 revisions)
  118. Exemption level‏‎ (2 revisions)
  119. Tissue equivalent material‏‎ (2 revisions)
  120. Myocardial stress test‏‎ (2 revisions)
  121. Oversight‏‎ (2 revisions)
  122. Projected dose‏‎ (2 revisions)
  123. Co-expertise‏‎ (2 revisions)
  124. Radionuclides of natural origin‏‎ (2 revisions)
  125. Connective tissue‏‎ (2 revisions)
  126. Recovery (cellular or tissue)‏‎ (2 revisions)
  127. DRL process‏‎ (2 revisions)
  128. Reversibility‏‎ (2 revisions)
  129. In vivo radiobioassay‏‎ (2 revisions)
  130. Solar particle event‏‎ (2 revisions)
  131. Effective dose equivalent‏‎ (2 revisions)
  132. Existing exposure situation‏‎ (2 revisions)
  133. Gastroschisis‏‎ (2 revisions)
  134. Worker‏‎ (2 revisions)
  135. Nuclear track detectors‏‎ (2 revisions)
  136. Angiogenesis‏‎ (2 revisions)
  137. Hyperbaric oxygen‏‎ (2 revisions)
  138. Bioturbation‏‎ (2 revisions)
  139. Cardioverter-defibrillator‏‎ (2 revisions)
  140. Radiation safety officer‏‎ (2 revisions)
  141. Radioresponsiveness‏‎ (2 revisions)
  142. Consequential late effects‏‎ (2 revisions)
  143. Recovery responder‏‎ (2 revisions)
  144. Rehabilitation of living conditions‏‎ (2 revisions)
  145. Right to know‏‎ (2 revisions)
  146. Incidence‏‎ (2 revisions)
  147. Solar wind‏‎ (2 revisions)
  148. Epithelium‏‎ (2 revisions)
  149. Target tissue‏‎ (2 revisions)
  150. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  151. Acceptance test‏‎ (2 revisions)
  152. Gastrulation‏‎ (2 revisions)
  153. Working level‏‎ (2 revisions)
  154. OLINDA/EXM‏‎ (2 revisions)
  155. Habitual mouth breather‏‎ (2 revisions)
  156. Annihilation photons‏‎ (2 revisions)
  157. Particle radiance‏‎ (2 revisions)
  158. Hyperfractionation‏‎ (2 revisions)
  159. Bone marrow‏‎ (2 revisions)
  160. Protection strategy‏‎ (2 revisions)
  161. Radiation source‏‎ (2 revisions)
  162. Cohort study‏‎ (2 revisions)
  163. Radiosensitiser‏‎ (2 revisions)
  164. DRL value‏‎ (2 revisions)
  165. Rigidity‏‎ (2 revisions)
  166. Dose-length product‏‎ (2 revisions)
  167. Security‏‎ (2 revisions)
  168. Incident‏‎ (2 revisions)
  169. Intermediate level waste‏‎ (2 revisions)
  170. Stenosis‏‎ (2 revisions)
  171. Equieffective dose‏‎ (2 revisions)
  172. Local DRL‏‎ (2 revisions)
  173. Expanded and aligned radiation field‏‎ (2 revisions)
  174. Tolerability‏‎ (2 revisions)
  175. Medical exposure‏‎ (2 revisions)
  176. Naturally occurring radioactive material‏‎ (2 revisions)
  177. Adventitious‏‎ (2 revisions)
  178. Working level month‏‎ (2 revisions)
  179. Habitual nose breather‏‎ (2 revisions)
  180. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  181. Background dose (rate)‏‎ (2 revisions)
  182. Radiosensitivity, cellular‏‎ (2 revisions)
  183. Containment‏‎ (2 revisions)
  184. Detriment‏‎ (2 revisions)
  185. Dose-rate effect‏‎ (2 revisions)
  186. Inclusiveness‏‎ (2 revisions)
  187. Source-related‏‎ (2 revisions)
  188. Internal conversion electron‏‎ (2 revisions)
  189. Electron-capture decay‏‎ (2 revisions)
  190. LD 50/30‏‎ (2 revisions)
  191. Telangiectasia‏‎ (2 revisions)
  192. Member of the public‏‎ (2 revisions)
  193. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  194. Unattached fraction‏‎ (2 revisions)
  195. Necrosis‏‎ (2 revisions)
  196. Patient entrance reference point‏‎ (2 revisions)
  197. Hypoplasia‏‎ (2 revisions)
  198. Backscatter detection system‏‎ (2 revisions)
  199. Potential recoverability correction factor‏‎ (2 revisions)
  200. Bradycardia‏‎ (2 revisions)
  201. Protective action guide‏‎ (2 revisions)
  202. Radiation worker‏‎ (2 revisions)
  203. Decay constant‏‎ (2 revisions)
  204. Self-help protection‏‎ (2 revisions)
  205. Individual-related‏‎ (2 revisions)
  206. Dose of record Hp (10)‏‎ (2 revisions)
  207. Electrophysiology‏‎ (2 revisions)
  208. Storage‏‎ (2 revisions)
  209. Track structure‏‎ (2 revisions)
  210. Mendelian diseases‏‎ (2 revisions)
  211. Accreditation‏‎ (2 revisions)
  212. Neurological syndrome‏‎ (2 revisions)
  213. Genomic integrity‏‎ (2 revisions)
  214. Occupational exposure‏‎ (2 revisions)
  215. Hazard‏‎ (2 revisions)
  216. Peak skin dose‏‎ (2 revisions)
  217. Bragg peak‏‎ (2 revisions)
  218. Radioactive dispersion device‏‎ (2 revisions)
  219. Radon: Units of Measure‏‎ (2 revisions)
  220. Coronary heart disease‏‎ (2 revisions)
  221. Reference air kerma‏‎ (2 revisions)
  222. Decommissioning‏‎ (2 revisions)
  223. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  224. Dose-threshold‏‎ (2 revisions)
  225. Individual decontamination‏‎ (2 revisions)
  226. Subcutaneous tissue‏‎ (2 revisions)
  227. Low dose rate‏‎ (2 revisions)
  228. Transfer compartment‏‎ (2 revisions)
  229. Mitigation‏‎ (2 revisions)
  230. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  231. Action Level‏‎ (2 revisions)
  232. Upper reference levels‏‎ (2 revisions)
  233. Neurovascular syndrome‏‎ (2 revisions)
  234. Health Surveillance‏‎ (2 revisions)
  235. Pelagic‏‎ (2 revisions)
  236. Basal cell‏‎ (2 revisions)
  237. Practical radiological protection culture‏‎ (2 revisions)
  238. Branching fraction‏‎ (2 revisions)
  239. Chronic exposure‏‎ (2 revisions)
  240. Radioactive source‏‎ (2 revisions)
  241. Colony‏‎ (2 revisions)
  242. Cosmic Radiation in Aviation‏‎ (2 revisions)
  243. Decontamination‏‎ (2 revisions)
  244. Relocation‏‎ (2 revisions)
  245. Diastasis‏‎ (2 revisions)
  246. Risk coefficient‏‎ (2 revisions)
  247. Individual monitoring‏‎ (2 revisions)
  248. Dose per unit intake coefficient‏‎ (2 revisions)
  249. Source term‏‎ (2 revisions)
  250. Emergency‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)